- Email: [email protected]
Cleantech Invest increases its stake in Sofi Filtration
news
Clarcor exits packaging to focus on filtration
Cleantech Invest increases its stake in Sofi Filtration
C
F
larcor Inc has sold its packaging subsidiary JL Clark Inc to CC Industries Inc, an affiliate of Chicagobased Henry Crown and Co to concentrate solely on filtration. JL Clark, the original business of Clarcor, designs and manufactures specialty metal and plastic packaging for consumer product customers. Headquartered in Rockford, Illinois, the 111 year-old business has annual revenues of US$77 million and around 350 employees. JL Clark was the sole operating company in Clarcor’s packaging segment. “Today is a bittersweet but exciting day for both Clarcor and JL Clark,” said Christopher Conway, Clarcor’s chairman, president and CEO. “As we looked to the future and our strategic priorities, we reluctantly determined that the time is right for us to exit the packaging industry, a decision that benefits not only Clarcor, but JL Clark as well. The simple truth is that, as a filtration company, we have not been able to give JL Clark the strategic focus and energy that the company and its dedicated employees deserve.”
inland’s Cleantech Invest plc has made a follow-on investment in portfolio company Sofi Filtration. Cleantech Invest has joined an investment round and increased its ownership of Sofi Filtration from 22% to 23.1%. Espoo, Finland-based Sofi Filtration has developed a self-cleaning filter that is able to treat large streams of water containing fine particle contamination, which are difficult to treat with traditional methods. The company says its solution has been successfully delivered to the mining industry and that tests in the energy industry with paying customers show very good results. Alexander Lidgren, managing director of Cleantech Invest, said: “Sofi Filtration has found its star applications in mining and energy production. The company is already delivering its solutions to key target customers and is in a good position to grow.” Cleantech Invest recently acquired a 10% interest in Eagle Filters Oy, a Finnish provider of air filtration solutions for gas fired power plants (see Filtration Industry Analyst, June 2015).
For further information, visit www.clarcor.com and www.jlclark.com
For further information, visit www.cleantechinvest.com and www.sofifiltration.com
Exchange Rates against the US Dollar Date: 24.7.2015 Country
Rate
Country
Rate
Australia A$1.37
Netherlands
Austria
E0.91
Norway NOK8.21
Belgium
E0.91
E0.91
Philippines Peso45.56
Canada C$1.30
Singapore S$1.37
China CNY6.21
South Africa
R12.64 KRW1171.40
Denmark DKK6.80
South Korea
Finland
E0.91
Spain
France
E0.91
Sweden SEK8.59
Germany
E0.91
Switzerland CHF0.96
India Rs64.11
Taiwan T$31.50
Italy
E0.91
Thailand Bt34.92
Japan ¥123.81
UK £0.64
Malaysia Rt3.82
USA US$1.00
16
Filtration Industry Analyst
Editorial Office: Elsevier Limited The Boulevard, Langford Lane Kidlington Oxford OX5 1GB United Kingdom Tel: +44 (0) 1865 843695 Web: www.filtrationindustryanalyst.com Editor: Roisin Reidy E-mail: [email protected] Production Support Manager: Lin Lucas E-mail: [email protected] Executive Publisher: Laney Zhou Subscription Information An annual subscription to Filtration Industry Analyst includes 12 issues and online access for up to 5 users. Prices: E1429 for all European countries & Iran US$1602 for all countries except Europe and Japan ¥190 000 for Japan (Prices valid until 31 December 2015) Subscriptions run for 12 months, from the date payment is received. More information: http://store.elsevier.com/product.jsp?isbn=13656937 Permissions may be sought directly from Elsevier Global Rights Department, PO Box 800, Oxford OX5 1DX, UK; phone: +44 1865 843830, fax: +44 1865 853333, email: [email protected]. You may also contact Global Rights directly through Elsevier’s home page (www.elsevier.com), selecting first ‘Support & contact’, then ‘Copyright & permission’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: +1 978 750 8400, fax: +1 978 750 4744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: +44 (0)20 7631 5555; fax: +44 (0)20 7631 5500. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the Publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher. Address permissions requests to: Elsevier Science Global Rights Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/ or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
E0.91
Digitally Produced by Mayfield Press (Oxford) LImited 12976
July 2015
Clarcor exits packaging to focus on filtration
Cleantech Invest increases its stake in Sofi Filtration
C
F
larcor Inc has sold its packaging subsidiary JL Clark Inc to CC Industries Inc, an affiliate of Chicagobased Henry Crown and Co to concentrate solely on filtration. JL Clark, the original business of Clarcor, designs and manufactures specialty metal and plastic packaging for consumer product customers. Headquartered in Rockford, Illinois, the 111 year-old business has annual revenues of US$77 million and around 350 employees. JL Clark was the sole operating company in Clarcor’s packaging segment. “Today is a bittersweet but exciting day for both Clarcor and JL Clark,” said Christopher Conway, Clarcor’s chairman, president and CEO. “As we looked to the future and our strategic priorities, we reluctantly determined that the time is right for us to exit the packaging industry, a decision that benefits not only Clarcor, but JL Clark as well. The simple truth is that, as a filtration company, we have not been able to give JL Clark the strategic focus and energy that the company and its dedicated employees deserve.”
inland’s Cleantech Invest plc has made a follow-on investment in portfolio company Sofi Filtration. Cleantech Invest has joined an investment round and increased its ownership of Sofi Filtration from 22% to 23.1%. Espoo, Finland-based Sofi Filtration has developed a self-cleaning filter that is able to treat large streams of water containing fine particle contamination, which are difficult to treat with traditional methods. The company says its solution has been successfully delivered to the mining industry and that tests in the energy industry with paying customers show very good results. Alexander Lidgren, managing director of Cleantech Invest, said: “Sofi Filtration has found its star applications in mining and energy production. The company is already delivering its solutions to key target customers and is in a good position to grow.” Cleantech Invest recently acquired a 10% interest in Eagle Filters Oy, a Finnish provider of air filtration solutions for gas fired power plants (see Filtration Industry Analyst, June 2015).
For further information, visit www.clarcor.com and www.jlclark.com
For further information, visit www.cleantechinvest.com and www.sofifiltration.com
Exchange Rates against the US Dollar Date: 24.7.2015 Country
Rate
Country
Rate
Australia A$1.37
Netherlands
Austria
E0.91
Norway NOK8.21
Belgium
E0.91
E0.91
Philippines Peso45.56
Canada C$1.30
Singapore S$1.37
China CNY6.21
South Africa
R12.64 KRW1171.40
Denmark DKK6.80
South Korea
Finland
E0.91
Spain
France
E0.91
Sweden SEK8.59
Germany
E0.91
Switzerland CHF0.96
India Rs64.11
Taiwan T$31.50
Italy
E0.91
Thailand Bt34.92
Japan ¥123.81
UK £0.64
Malaysia Rt3.82
USA US$1.00
16
Filtration Industry Analyst
Editorial Office: Elsevier Limited The Boulevard, Langford Lane Kidlington Oxford OX5 1GB United Kingdom Tel: +44 (0) 1865 843695 Web: www.filtrationindustryanalyst.com Editor: Roisin Reidy E-mail: [email protected] Production Support Manager: Lin Lucas E-mail: [email protected] Executive Publisher: Laney Zhou Subscription Information An annual subscription to Filtration Industry Analyst includes 12 issues and online access for up to 5 users. Prices: E1429 for all European countries & Iran US$1602 for all countries except Europe and Japan ¥190 000 for Japan (Prices valid until 31 December 2015) Subscriptions run for 12 months, from the date payment is received. More information: http://store.elsevier.com/product.jsp?isbn=13656937 Permissions may be sought directly from Elsevier Global Rights Department, PO Box 800, Oxford OX5 1DX, UK; phone: +44 1865 843830, fax: +44 1865 853333, email: [email protected]. You may also contact Global Rights directly through Elsevier’s home page (www.elsevier.com), selecting first ‘Support & contact’, then ‘Copyright & permission’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: +1 978 750 8400, fax: +1 978 750 4744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: +44 (0)20 7631 5555; fax: +44 (0)20 7631 5500. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the Publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher. Address permissions requests to: Elsevier Science Global Rights Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/ or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
E0.91
Digitally Produced by Mayfield Press (Oxford) LImited 12976
July 2015